Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 08-2025 | 05-2025 | 02-2025 | 11-2024 | 08-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 382 | 409 | 525 | 136 | 229 |
| Receivables | 8 | 11 | 6 | 4 | 4 |
| TOTAL | $402 | $447 | $558 | $180 | $244 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 5 | 5 | 5 | 5 | 5 |
| TOTAL | $5 | $5 | $5 | $5 | $5 |
| Total Assets | $407 | $452 | $563 | $185 | $249 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18 | N/A | N/A | 17 | 20 |
| TOTAL | $18 | $16 | $63 | $17 | $20 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 23 | 0 |
| TOTAL | $0 | $0 | $0 | $23 | $0 |
| Total Liabilities | $18 | $16 | $63 | $40 | $20 |
| Shareholders' Equity | |||||
| Common Shares | 20,608 | 20,608 | 20,608 | 20,108 | 20,061 |
| Retained earnings | -20,946 | -20,899 | -21,070 | -20,925 | -21,542 |
| Other shareholders' equity | 727 | 727 | 962 | 962 | 1,710 |
| TOTAL | $389 | $436 | $500 | $145 | $229 |
| Total Liabilities And Equity | $407 | $452 | $563 | $185 | $249 |